Sarah Boyce
Affiliations
- Director at Contineum Therapeutics Inc. (CTNM), 2026-06-26
- Insider at Atrium Therapeutics Inc. (RNA), 2026-03-02
- President and Ceo at Avidity Biosciences Inc. (RNAM), 2026-02-27
- Director at Omniab Inc. (OABI), 2024-06-21
- Other at Ligand Pharmaceuticals Inc (LGND), 2022-11-04
- Director at Berkeley Lights Inc. (BLI), 2021-05-19
- President at Akcea Therapeutics Inc. (AKCA), 2019-07-17
- Chief Business Officer at Ionis Pharmaceuticals Inc (IONS), 2018-01-18
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| OABI | $2.92 | 15,000 | $43,800.00 | 36,000 | 2022-11-10 | Filing |
| OABI | $2.74 | 21,000 | $57,596.70 | 21,000 | 2022-11-09 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| RNA | $72.45 | 7,993 | $579,092.85 | 269,007 | 2026-01-21 | Filing |
| RNA | $72.45 | 6,394 | $463,245.30 | 277,000 | 2026-01-21 | Filing |
| RNA | $72.23 | 8,576 | $619,444.48 | 283,394 | 2026-01-07 | Filing |
| RNA | $49.95 | 50,000 | $2,497,435.00 | 305,871 | 2025-09-05 | Filing |
| RNA | $49.39 | 25,000 | $1,234,700.00 | 305,871 | 2025-08-28 | Filing |